Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 12447733)

1.

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.

Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM, Kerr C.

J Infect Dis. 2002 Dec 1;186(11):1582-8. Epub 2002 Nov 6.

2.

Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.

Höffken G, Gillissen A.

Med Microbiol Immunol. 2002 Dec;191(3-4):169-73. Epub 2002 Sep 11. Review.

PMID:
12458354
3.

Neuraminidase inhibitors: zanamivir and oseltamivir.

McNicholl IR, McNicholl JJ.

Ann Pharmacother. 2001 Jan;35(1):57-70. Review.

PMID:
11197587
4.

Spotlight on zanamivir in influenza.

Cheer SM, Wagstaff AJ.

Am J Respir Med. 2002;1(2):147-52. Review.

PMID:
14720068
5.

Zanamivir: from drug design to the clinic.

Elliott M.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1885-93. Review.

6.

Zanamivir.

Waghorn SL, Goa KL.

Drugs. 1998 May;55(5):721-5; discussion 725-7. Review.

PMID:
9585868
7.

Zanamivir: an update of its use in influenza.

Cheer SM, Wagstaff AJ.

Drugs. 2002;62(1):71-106. Review.

PMID:
11790157
8.

[Efficacy of inhaled zanamivir in the treatment and prevention of influenza].

Abad-Santos F, Gallego Sandín S, Novalbos Reina J, Martínez Sancho E, Gálvez Múgica MA.

An Med Interna. 2001 Feb;18(2):93-9. Review. Spanish.

PMID:
11322008
9.

Zanamivir: a rational approach to influenza B.

Penn CR, Osterhaus A.

Scand J Infect Dis. 2001;33(1):33-40. Review.

PMID:
11234975
10.

Managing influenza: amantadine, rimantadine and beyond.

Fleming DM.

Int J Clin Pract. 2001 Apr;55(3):189-95. Review.

PMID:
11351773
11.

Neuraminidase inhibitors for the treatment and prevention of influenza.

McKimm-Breschkin JL.

Expert Opin Pharmacother. 2002 Feb;3(2):103-12. Review.

PMID:
11829724
12.

Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications.

Gravenstein S, Johnston SL, Loeschel E, Webster A.

Drug Saf. 2001;24(15):1113-25. Review.

PMID:
11772145
13.

Zanamivir in the treatment and prevention of influenza.

Chapple KJ, Hendrick AE, McCarthy MW.

Ann Pharmacother. 2000 Jun;34(6):798-801. Review.

PMID:
10860141
14.

Effectiveness and role of zanamivir in the treatment of influenza infection.

Silagy CA, Campion K.

Ann Med. 1999 Oct;31(5):313-7. Review.

PMID:
10574503
15.
16.

What is the best antiviral agent for influenza infection?

Fagan HB, Moeller AH.

Am Fam Physician. 2004 Oct 1;70(7):1331-2. Review. No abstract available.

17.

Underused options for preventing and treating influenza.

Mossad SB.

Cleve Clin J Med. 1999 Jan;66(1):19-23. Review.

PMID:
9926627
18.

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.

Burls A, Clark W, Stewart T, Preston C, Bryan S, Jefferson T, Fry-Smith A.

Health Technol Assess. 2002;6(9):1-87. Review. No abstract available.

19.

Neuraminidase inhibitors in patients with underlying airways disease.

Williamson JC, Pegram PS.

Am J Respir Med. 2002;1(2):85-90. Review.

PMID:
14720062
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk